Basics
Description
- Atopic dermatitis is the most common cause of eczema and the terms are often used synonymously.
- Associated with allergic diseases such as asthma and allergic rhinitis
- Eczema literally means "out boil" and refers to spongiosis, the process where microvesicles form and rupture, leaving erythema, edema, crusting, and oozing
- Pruritus is highly characteristic
- Patient rub and scratch skin breakdown with oozing and crusting
- Chronically this causes epidermal hyperplasia and hyperkeratosis
- 90% of patients colonize with Staphylococcus aureus, and are prone to episodes of superinfection
Risk Factors
Genetics
- Family history of atopy (asthma, allergic rhinitis) typical
- Mutation of the filaggrin protein, part of the epidermal barrier, is strongly associated
Etiology
Atopic dermatitis is caused by a deficit in epidermal integrity that allows foreign substances to enter and trigger immune responses.
Diagnosis
Signs and Symptoms
History
- Rash, pruritus, and atopy traditionally prompt the diagnosis
- UK diagnostic criteria = pruritus and 3 of the following:
- Flexural distribution
- Atopic history (asthma or allergic rhinitis)
- History of dry skin
- Onset age <2 yr
- Objective signs of flexural dermatitis
- Additional findings:
- Cutaneous infections
- Itch when sweating
- Intolerance to wool and lipid solvents
- Triggered by stress
Physical Exam
Dermatitis, located on areas of trauma or motion such as hands and feet and flexural areas
- Epidermal compromise:
- Dry skin
- Weeping
- Oozing
- Finally crusting
- Inflammation:
- Maculopapular erythema
- Edema
- Scratching leads to:
- Excoriation
- Cracking
- Lichenification
- Hyperkeratosis
- Additional findings:
- Icthyosis, palmar hyperlinearity, keratosis pilaris
- Hand or foot dermatitis
- Nipple eczema
- Cheilitis
- Dennie-Morgan infraorbital fold
- Orbital darkening
- Facial pallor or facial erythema
- Pityriasis alba
- Perifollicular accentuation
- White dermographism or delayed blanch
- 70% of all cases begin during the 1st 5 yr of life
- Only 10% of cases start in adulthood
- 30% of children with atopic dermatitis develop asthma, 35% develop allergic rhinitis
- Infant distribution is classically extensor surfaces and head and face
Essential Workup
History and physical exam
Diagnosis Tests & Interpretation
Lab
- Clinical diagnosis
- IgE commonly elevated but does not usually need to be tested
Diagnostic Procedures/Surgery
Generally reserved for settings outside of the ED:
- Radioallergosorbent test (RAST) sometimes used to identify allergic triggers
- Patch testing used if contact dermatitis is suspected
Differential Diagnosis
- Seborrheic dermatitis
- Neurodermatitis (lichen simplex chronicus)
- Allergic contact dermatitis
- Irritant dermatitis
- Psoriasis
- Dyshidrosis
- Ichthyosis
- Scabies
Treatment
Ed Treatment/Procedures
- Mild disease or disease of the head and neck:
- Low-potency corticosteroids such as hydrocortisone 1-2.5%
- Eucerin cream: Apply to affected areas BID
- Moderate or severe disease of the trunk and extremities:
- Higher-potency corticosteroids such as triamcinolone 0.1% (moderate potency) or fluocinonide 0.05% ointment (high potency)
- Severe disease of the head and neck:
- Topical calcineurin inhibitors such as pimecrolimus and tacrolimus
- 1st-generation antihistamines:
- Diphenhydramine, hydroxyzine are used for relief of itching but are only weakly effective
- Behavioral interventions:
- Avoid excessive bathing
- Use of tepid water and mild soaps
- Frequent use of emollients (Eucerin cream, Aquaphor ointment)
- Bacterial superinfection: Cephalexin, cefazolin:
Medication
- Aquaphor ointment: Apply to affected areas BID
- Cephalexin: 500 mg (peds: 25-100 mg/kg/24h) PO q6h
- Diphenhydramine: 25-50 mg (peds: 5 mg/kg/24h) PO or IV q6h
- Eucerin cream: Apply to affected areas BID
- Fluocinonide 0.05% ointment: Apply to affected areas of body BID for the duration of the flare (high potency)
- Hydrocortisone 2.5% ointment: Apply to affected areas of body/face BID for the duration of the flare (low potency)
- Hydroxyzine: 25-100 mg (peds: 2 mg/kg/24h) PO q4-6h
- Pimecrolimus 1% cream: Apply to affected areas BID (peds: >2 yr of age) for the duration of the flare
- Tacrolimus ointment: 0.1% (peds: >2 yr of age: 0.03%) apply to affected areas BID for the duration of the flare
- Triamcinolone 0.1% ointment: Apply to affected areas of body BID for the duration of the flare (mid potency)
First Line
- Hydrocortisone 2.5% ointment: Apply to affected areas of body/face BID for the duration of the flare (low potency)
- Aquaphor ointment: Apply to affected areas BID
Second Line
- Triamcinolone 0.1% ointment: Apply to affected areas of body BID for the duration of the flare (mid potency)
- Avoid the face and eyelids
- Fluocinonide 0.05% ointment: Apply to affected areas of body BID for the duration of the flare (high potency)
- Avoid the face and eyelids
- Tacrolimus ointment: 0.1% (peds: >2 yr of age: 0.03%) apply to affected areas BID for the duration of the flare
- Pimecrolimus 1% cream: Apply to affected areas BID (peds: >2 yr of age) for the duration of the flare
Follow-Up
Disposition
Issues for Referral
Dermatology referral for problematic cases
Follow-Up Recommendations
- Patients should be warned of adverse consequences of treatment:
- High-potency steroids can cause thinning of the skin
- Tacrolimus and pimecrolimus cause a stinging sensation for the 1st wk of therapy. Long term use can increase risk of cancer
Pearls and Pitfalls
- Consider secondary cellulitis, as 90% of patients with atopic dermatitis are eventually colonized with S. aureus
- Use tacrolimus and pimecrolimus for moderate to severe disease of the head and neck
- Consider in any patient with a severely pruritic rash
- Lotions have low lipid content and can cause drying
- Heavy creams are preferred
- Do not use triamcinolone or fluocinonide on face or eyelids
Additional Reading
- Beltrani VS. Suggestions regarding a more appropriate understanding of atopic dermatitis. Curr Opin Allergy Clin Immunol. 2005;5:413-418.
- Bieber T. Atopic dermatitis. N Engl J Med. 2008;358:1483-1494.
- Wasserbauer N, Ballow M. Atopic dermatitis. Am J Med. 2009;122:121-125.
- Williams HC. Clinical practice: Atopic dermatitis. N Engl J Med. 2005;352:2314-2324.
- Zheng T, Yu J, Oh MH, et al. The atopic march: Progression from atopic dermatitis to allergic rhinitis and asthma. Allergy Asthma Immunol Res. 2011;3:67-73.
See Also (Topic, Algorithm, Electronic Media Element)
Codes
ICD9
- 691.8 Other atopic dermatitis and related conditions
- 692.9 Contact dermatitis and other eczema, unspecified cause
ICD10
- L20.9 Atopic dermatitis, unspecified
- L20.82 Flexural eczema
- L30.9 Dermatitis, unspecified
- L20.89 Other atopic dermatitis
SNOMED
- 43116000 Eczema (disorder)
- 24079001 Atopic dermatitis (disorder)
- 57092006 Flexural eczema (disorder)
- 238541000 Atopic dermatitis of hands (disorder)
- 200775004 Atopic neurodermatitis (disorder)